FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103409603> ?p ?o ?g. }

• W2103409603 endingPage "1113" @default.
• W2103409603 startingPage "1105" @default.
• W2103409603 abstract "Smooth-muscle calcium-activated large-conductance potassium channels (BK channels) are activated by tamoxifen and 17-β-estradiol. This increase in NP_o, the number of channels, N, multiplied by open probability, depends on the presence of the regulatory β1-subunit. Furthermore, a previous study indicated that 17-β-estradiol might bind an extracellular site on the β1-subunit. Because tamoxifen and 17-β-estradiol may share a common binding site, we hypothesized that tamoxifen activates BK channels through a site on the extracellular surface of the membrane. A membrane-impermeant analog of tamoxifen, ethylbromide tamoxifen, was synthesized and used to test this hypothesis in whole-cell, outside-out, cell-attached, and inside-out patches from canine colonic smooth muscle cells. Ethylbromide tamoxifen is positively charged and is therefore membrane-impermeant. In whole-cell experiments, ethylbromide tamoxifen increased K⁺ current at potentials positive to +40 mV, which has previously been attributed to BK channels. Unlike tamoxifen, ethylbromide tamoxifen did not inhibit delayed rectifier current. In outside-out patches, ethylbromide tamoxifen increased BK channel NP_o with an EC₅₀value of 1 μM. Ethylbromide tamoxifen did not increase BK channel NP_o in cell-attached or inside-out patches; however, subsequent addition of equimolar tamoxifen did. Both drugs diminished BK channel unitary conductance to a degree that paralleled the effect on NP_o, suggesting an additional interaction with the pore-forming α-subunit. An interaction of tamoxifen with the pore was supported by a right shift in the concentration-response curve for tetraethylammonium; similar results were evident with iberiotoxin and charybdotoxin block. Our data suggest that ethylbromide tamoxifen does not easily traverse the plasma membrane and that tamoxifen binding responsible for activation of BK channels is at an extracellular site. The tamoxifen binding site may be within the extracellular loop of the BK channel β1-subunit or, alternatively, on an as-yet-unidentified mediator that has an extracellular binding site." @default.
• W2103409603 created "2016-06-24" @default.
• W2103409603 creator A5028080442 @default.
• W2103409603 creator A5030129626 @default.
• W2103409603 creator A5038570981 @default.
• W2103409603 date "2002-05-01" @default.
• W2103409603 modified "2023-09-29" @default.
• W2103409603 title "Ethylbromide Tamoxifen, a Membrane-Impermeant Antiestrogen, Activates Smooth Muscle Calcium-Activated Large-Conductance Potassium Channels from the Extracellular Side" @default.
• W2103409603 cites W1519345480 @default.
• W2103409603 cites W1531318853 @default.
• W2103409603 cites W1562190372 @default.
• W2103409603 cites W1602374960 @default.
• W2103409603 cites W1854945595 @default.
• W2103409603 cites W1988332161 @default.
• W2103409603 cites W1989446922 @default.
• W2103409603 cites W2014264924 @default.
• W2103409603 cites W2016866576 @default.
• W2103409603 cites W2021710212 @default.
• W2103409603 cites W2029489419 @default.
• W2103409603 cites W2030306537 @default.
• W2103409603 cites W2030336802 @default.
• W2103409603 cites W2045104181 @default.
• W2103409603 cites W2054508943 @default.
• W2103409603 cites W2058758240 @default.
• W2103409603 cites W2060153480 @default.
• W2103409603 cites W2063333407 @default.
• W2103409603 cites W2065372134 @default.
• W2103409603 cites W2078019741 @default.
• W2103409603 cites W2097033636 @default.
• W2103409603 cites W2132882998 @default.
• W2103409603 cites W2137267834 @default.
• W2103409603 cites W2147620979 @default.
• W2103409603 cites W2147682631 @default.
• W2103409603 cites W2149635665 @default.
• W2103409603 cites W2164566530 @default.
• W2103409603 cites W2248460896 @default.
• W2103409603 cites W2465187776 @default.
• W2103409603 cites W50496392 @default.
• W2103409603 doi "https://doi.org/10.1124/mol.61.5.1105" @default.
• W2103409603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11961128" @default.
• W2103409603 hasPublicationYear "2002" @default.
• W2103409603 type Work @default.
• W2103409603 sameAs 2103409603 @default.
• W2103409603 citedByCount "35" @default.
• W2103409603 countsByYear W21034096032012 @default.
• W2103409603 countsByYear W21034096032013 @default.
• W2103409603 countsByYear W21034096032014 @default.
• W2103409603 countsByYear W21034096032015 @default.
• W2103409603 countsByYear W21034096032016 @default.
• W2103409603 countsByYear W21034096032020 @default.
• W2103409603 crossrefType "journal-article" @default.
• W2103409603 hasAuthorship W2103409603A5028080442 @default.
• W2103409603 hasAuthorship W2103409603A5030129626 @default.
• W2103409603 hasAuthorship W2103409603A5038570981 @default.
• W2103409603 hasConcept C121608353 @default.
• W2103409603 hasConcept C12554922 @default.
• W2103409603 hasConcept C126322002 @default.
• W2103409603 hasConcept C134018914 @default.
• W2103409603 hasConcept C181911157 @default.
• W2103409603 hasConcept C185592680 @default.
• W2103409603 hasConcept C2776067312 @default.
• W2103409603 hasConcept C2777176818 @default.
• W2103409603 hasConcept C2780419564 @default.
• W2103409603 hasConcept C28406088 @default.
• W2103409603 hasConcept C41625074 @default.
• W2103409603 hasConcept C530470458 @default.
• W2103409603 hasConcept C55493867 @default.
• W2103409603 hasConcept C61144316 @default.
• W2103409603 hasConcept C71924100 @default.
• W2103409603 hasConcept C83743174 @default.
• W2103409603 hasConcept C86803240 @default.
• W2103409603 hasConceptScore W2103409603C121608353 @default.
• W2103409603 hasConceptScore W2103409603C12554922 @default.
• W2103409603 hasConceptScore W2103409603C126322002 @default.
• W2103409603 hasConceptScore W2103409603C134018914 @default.
• W2103409603 hasConceptScore W2103409603C181911157 @default.
• W2103409603 hasConceptScore W2103409603C185592680 @default.
• W2103409603 hasConceptScore W2103409603C2776067312 @default.
• W2103409603 hasConceptScore W2103409603C2777176818 @default.
• W2103409603 hasConceptScore W2103409603C2780419564 @default.
• W2103409603 hasConceptScore W2103409603C28406088 @default.
• W2103409603 hasConceptScore W2103409603C41625074 @default.
• W2103409603 hasConceptScore W2103409603C530470458 @default.
• W2103409603 hasConceptScore W2103409603C55493867 @default.
• W2103409603 hasConceptScore W2103409603C61144316 @default.
• W2103409603 hasConceptScore W2103409603C71924100 @default.
• W2103409603 hasConceptScore W2103409603C83743174 @default.
• W2103409603 hasConceptScore W2103409603C86803240 @default.
• W2103409603 hasIssue "5" @default.
• W2103409603 hasLocation W21034096031 @default.
• W2103409603 hasLocation W21034096032 @default.
• W2103409603 hasOpenAccess W2103409603 @default.
• W2103409603 hasPrimaryLocation W21034096031 @default.
• W2103409603 hasRelatedWork W1969880518 @default.
• W2103409603 hasRelatedWork W1970225649 @default.
• W2103409603 hasRelatedWork W2016247671 @default.
• W2103409603 hasRelatedWork W2033320539 @default.
• W2103409603 hasRelatedWork W2103409603 @default.

• next